Treating Europe’s healthcare malaise
With an ageing population and a sharp rise in long-term chronic illnesses putting a strain on the continent’s healthcare provision, unquote" investigates private equity’s role in solving Europe’s healthcare conundrum
There are few industries that stir public emotion as strongly as the healthcare sector. As conflicting ideological parties squabble over the merits of a private market model versus the sector's role as a vital public service, the developed world finds itself facing the conundrum of how it will meet an exponential increase in demand.
In this series, unquote" investigates how the sector is evolving, where the most prevalent opportunities lie and what challenges are faced by private equity players in the most mature markets.
France, Germany and southern Europe are emerging as the continent's most active markets for PE investment in healthcare provision
Taking the political pulse
Austerity measures are among the political developments resulting in an increasingly challenging environment for healthcare investors
Avoiding healthcare controversy and seeking new opportunities
As GPs shy away from investment in healthcare provision, new opportunities are presenting themselves in other medically related sub-sectors
Healthcare: A case study in reputational risk
PE investments in Nordic healthcare have become a controversial topic following the 'Carema scandal', which sparked ESG and transparency reforms
Nordic GPs look to new verticals in private healthcare
GPs in the region are increasingly turning to new healthcare subsectors as the private care segment evolves into a large-cap game
UK healthcare market still fighting fit post-Brexit
Momentous changes in the UK's healthcare provision space and the potential for growth in related subsectors present opportunities for private equity
VC-backed biotechs sustain faint pulse of Benelux healthcare
Uncertain policies have caused a slow down for healthcare buyouts in Benelux
Nordic PE healthcare deals in need of resuscitation
Dwindling healthcare dealflow belies the Nordic region's strong fundamentals